Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models

Archive ouverte

Vieujean, Sophie | Caron, Bénédicte | Haghnejad, Vincent | Jouzeau, Jean-Yves | Netter, Patrick | Heba, Anne-Charlotte | Ndiaye, Ndeye, Coumba | Moulin, David | Barreto, Guillermo | Danese, Silvio | Peyrin-Biroulet, Laurent

Edité par CCSD ; MDPI -

International audience. Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract that encompass two main phenotypes, namely Crohn’s disease and ulcerative colitis. These conditions occur in genetically predisposed individuals in response to environmental factors. Epigenetics, acting by DNA methylation, post-translational histones modifications or by non-coding RNAs, could explain how the exposome (or all environmental influences over the life course, from conception to death) could influence the gene expression to contribute to intestinal inflammation. We performed a scoping search using Medline to identify all the elements of the exposome that may play a role in intestinal inflammation through epigenetic modifications, as well as the underlying mechanisms. The environmental factors epigenetically influencing the occurrence of intestinal inflammation are the maternal lifestyle (mainly diet, the occurrence of infection during pregnancy and smoking); breastfeeding; microbiota; diet (including a low-fiber diet, high-fat diet and deficiency in micronutrients); smoking habits, vitamin D and drugs (e.g., IBD treatments, antibiotics and probiotics). Influenced by both microbiota and diet, short-chain fatty acids are gut microbiota-derived metabolites resulting from the anaerobic fermentation of non-digestible dietary fibers, playing an epigenetically mediated role in the integrity of the epithelial barrier and in the defense against invading microorganisms. Although the impact of some environmental factors has been identified, the exposome-induced epimutations in IBD remain a largely underexplored field. How these environmental exposures induce epigenetic modifications (in terms of duration, frequency and the timing at which they occur) and how other environmental factors associated with IBD modulate epigenetics deserve to be further investigated.

Suggestions

Du même auteur

Management of patients with inflammatory bowel disease and spondyloarthritis

Archive ouverte | Pouillon, Lieven | CCSD

International audience. Introduction: More than half of the patients with inflammatory bowel disease (IBD) experience at least one extra-intestinal manifestation (EIM). The most common EIM in patients with IBD is sp...

Gut microbiome in Chronic Rheumatic and Inflammatory Bowel Diseases: similarities and differences

Archive ouverte | Salem, Fatouma | CCSD

International audience. INTRODUCTION:Inflammatory bowel diseases (IBDs) and chronic rheumatic diseases (CRDs) are systemic chronic disorders sharing common genetic, immune and environmental factors. About half of pa...

Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience

Archive ouverte | Remy, Clotilde | CCSD

International audience. Background: Subcutaneous infliximab and vedolizumab formulations have been developed for maintenance therapy in inflammatory bowel disease. The objective of this study was to explore the infl...

Chargement des enrichissements...